VADDI KRISHNA (President, CEO) purchased 1.6% of their position (20.42K shares) of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $14.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/24/2025ACC: 0001562180-25-002697
DirectorOfficer· President, CEO
Since Sep 2020
+20.42K
Net shares
Net buyer
$14.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
20.42K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.42K
Price / share
$0.73
Trade value
$3.95K
% of position
0.4%
3/20/2025
1.30M→1.31M
Common Stock
Direct
Shares
+15K
Price / share
$0.73
Trade value
$10.96K
% of position
1.1%
3/21/2025
1.31M→1.32M
Total
Net shares
+20.42K
Net value
$14.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2025 | P · Purchase | +5.42K | $0.73 | $3.95K | 0.4% | 1.30M | 1.31M |
| Common Stock Direct | 3/21/2025 | P · Purchase | +15K | $0.73 | $10.96K | 1.1% | 1.31M | 1.32M |
| Total | +20.42K | $14.91K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned423.65K
Common Stock
IndirectShares owned142.55K
Common Stock
IndirectShares owned551.78K
Common Stock
IndirectShares owned551.77K
Total
1.67M indirect1.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 423.65K | Indirect |
| Common Stock | 142.55K | Indirect |
| Common Stock | 551.78K | Indirect |
| Common Stock | 551.77K | Indirect |
| Total | 1.67M | 1.67M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported